Bioanalytical Systems, Inc.’s working capital deficit dropped
31.3%, or roughly US$1.0 million, from US$3.3 million at Dec. 31,
2010, to US$2.3 million at March 31, 2011.
At March 31, 2011, the…
At March 31, 2010, Calypte Biomedical Corporation had a working capital deficit of US$16.5 million, including US$11.6 million in principal and accrued interest under the 8% convertible notes and 7%…
Patient Safety Technologies, Inc. had a working capital deficit of US$11,369,127 at December 31, 2009, of which US$8,000,000 and US$3,666,336, respectively, are associated with deferred revenue relating to the partial…
Calypte Biomedical Corporation had working capital deficits of US$16.6 million and US$14.5 million, at December 31, 2009, and 2008, respectively.
For the year ended December 31, 2009, the Company suffered a…
American Shared Hospital Services’ working capital deficit rose by 275%, or US$564,000, from US$205,000 at Dec. 31, 2008 to US$769,000 at March 31, 2009.
The Company reported US$14.88 million in current…
Patient Safety Technologies, Inc. reported a working capital deficit of US$5.69 million at Dec. 31, 2008, a 131% increase from US$2.46 million at Dec. 31, 2007.
The Company had US$1.10 million…
NeoGenomics, Inc. reported a working capital deficit of US$35,000 at Dec. 31, 2008, compared to a positive working capital of US$790,000 at Dec. 31, 2007.
The Company had US$4.35 million in…
GeoPharma, Inc. reported a working capital deficit of US$3.82 million at Dec. 31, 2008, compared to a positive working capital of US$1.15 million at March 31, 2008.
The Company had US$21.83…